Evidence map›Paper›PMID 36231103›Full record

ArticleCells2022

Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection.

Emil Johansson, Priscilla F Kerkman, Lydia Scharf, Jacob Lindman, Zsófia I Szojka, Fredrik Månsson, Antonio Biague, Patrik Medstrand, Hans Norrgren, Marcus Buggert and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Emil JohanssonDepartment of Laboratory Medicine, Lund University, 22184 Lund, Sweden.ORCID 0000-0002-4712-3687
Priscilla F KerkmanDepartment of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden.ORCID 0000-0002-6212-002X
Lydia ScharfDepartment of Laboratory Medicine, Karolinska Institutet, 14152 Huddinge, Sweden.
Jacob LindmanDepartment of Clinical Sciences Lund, Lund University, 22184 Lund, Sweden.
Zsófia I SzojkaDepartment of Laboratory Medicine, Lund University, 22184 Lund, Sweden.ORCID 0000-0002-1252-6929
Fredrik MånssonDepartment of Translational Medicine, Lund University, 20502 Malmö, Sweden.
Antonio BiagueNational Laboratory for Public Health, Bissau 1041, Guinea-Bissau.
Patrik MedstrandDepartment of Translational Medicine, Lund University, 20502 Malmö, Sweden.
Hans NorrgrenDepartment of Clinical Sciences Lund, Lund University, 22184 Lund, Sweden.
Marcus BuggertDepartment of Medicine Huddinge, Karolinska Institutet, 14186 Stockholm, Sweden.
Annika C KarlssonDepartment of Laboratory Medicine, Karolinska Institutet, 14152 Huddinge, Sweden.ORCID 0000-0002-2028-8393
Mattias N E ForsellDepartment of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden.ORCID 0000-0001-6904-742X
Joakim EsbjörnssonDepartment of Translational Medicine, Lund University, 20502 Malmö, Sweden.
Marianne JanssonDepartment of Laboratory Medicine, Lund University, 22184 Lund, Sweden.
The Swegub Core Group
Lund University · SEKarolinska Institutet · SENational Institute of Public Health · GWUmeå University · SEUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Time to AIDS in HIV-2 infection is approximately twice as long compared to in HIV-1 infection. Despite reduced viremia, HIV-2-infected individuals display signs of chronic immune activation. In HIV-1-infected individuals, B-cell hyperactivation is driven by continuous antigen exposure. However, the contribution of viremia to B-cell perturbations in HIV-2-infected individuals remains largely unexplored. Here, we used polychromatic flow cytometry, consensus hierarchical clustering and pseudotime trajectory inference to characterize B-cells in HIV-1- or HIV-2-infected and in HIV seronegative individuals. We observed increased frequencies of clusters containing hyperactivated T-bet

Indexed as

HIV-1HIV InfectionsHIV SeropositivityCluster AnalysisHIV-2HumansViremiaB-cell phenotypeCD95HIV-1HIV-2immune perturbationsT-betviremia

Identifiers

PMID36231103
PMCPMC9562922
OpenAlexW4303629037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.